MedPath

NSAID

Generic Name
NSAID

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Research Report

Published: Aug 27, 2025

Nonsteroidal Anti-inflammatory Drugs: A Comprehensive Clinical and Pharmacological Review

Section 1: Introduction to NSAIDs: A Cornerstone of Modern Pharmacotherapy

1.1. Defining the Drug Class and Its Historical Context

Nonsteroidal anti-inflammatory drugs (NSAIDs) represent a class of medications renowned for their analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties.[1] They are among the most widely prescribed and utilized therapeutic agents worldwide, forming the foundation of treatment for a vast array of acute and chronic conditions. The term "non-steroidal" itself provides a crucial historical insight into their development. Coined around 1960, it was specifically chosen to differentiate this emerging class of drugs from corticosteroids, which, despite their potent anti-inflammatory effects, had gained a negative reputation in the 1950s due to significant and often severe side effects associated with their overuse.[3] This distinction positioned NSAIDs as a new, seemingly safer alternative for managing inflammation and pain. This historical search for a therapeutic agent that could separate efficacy from toxicity is a recurring theme that has defined the evolution of NSAIDs, foreshadowing later developments such as the creation of COX-2 selective inhibitors, which were themselves an attempt to solve the toxicity problems of their predecessors.

1.2. Overview of Core Therapeutic Properties

The clinical utility of NSAIDs stems from their three primary pharmacological actions:

Continue reading the full research report

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.